Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PLRZ stock hub

Polyrizon Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PLRZis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PLRZ

In the news

Latest news · PLRZ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-25.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-29.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PLRZ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

USD

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001893645
Company name	Polyrizon Ltd.
Country	Israel
Country code	US
Cusip	M79549123
Employees	4
Enterprise value	$18.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-10-29
Isin	IL0011814113
Last refreshed	2026-05-10
Market cap	$30.6M
Market cap category	Nano-Cap
Price	$16.34
Price currency	USD
Sector	Healthcare
Sic	3841
Symbol	PLRZ
Website	https://www.polyrizon-biotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.9%
FCF yield	-14.83%
P/B ratio	1.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-3.3M
Net Income Growth Years	0%
Profit Per Employee	$-833,750
ROA	-28.95
Roa5y	-68.35
ROCE	-29.77
ROE	-25.38
ROIC	-29.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-98.34%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$21.4M
Cash	$12.3M
Current Assets	$12.9M
Current Liabilities	$443,000
Equity	$21M
Liabilities	$443,000
Long Term Assets	$8.6M
Long Term Liabilities	$0
Net Cash	$12.3M
Net Cash By Market Cap	$40.13
Net Debt Equity	$-0.58
Tangible Book Value	$18.4M
Tangible Book Value Per Share	$11.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	29.03
Net Working Capital	$144,000
Quick ratio	27.7
Working Capital	$12.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-98.33%
200-day SMA	9.85
50-day SMA	13.39
50-day SMA vs 200-day SMA	50over200
All Time High	7,200
All Time High Change	-99.77%
All Time High Date	2024-12-18
All Time Low	2.88
All Time Low Change	467.36%
All Time Low Date	2025-11-26
ATR	1.59
Beta1y	-1.53
Beta2y	1.98
Ch YTD	92.46
High	17.18
High52	1,052.3
High52 Date	2025-05-08
High52ch	-98.45%
Low	13.81
Low52	2.88
Low52 Date	2025-11-26
Low52ch	467.36%
Ma50ch	22.05%
Premarket Change Percent	-0.28
Premarket Price	$14.1
Price vs 200-day SMA	65.87%
RSI	62.52
RSI Monthly	32.35
RSI Weekly	39.66
Sharpe ratio	-0.01x
Sortino ratio	0
Tr YTD	92.46
Tr1m	47.47%
Tr1w	2.13%
Tr3m	27.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-6.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,648,878%
Float Percent	88.09%
Shares Insiders	4.59%
Shares Institutions	2.18%
Shares Out	1,871,848
Shares Qo Q	365.73%
Short Float	4.08%
Short Ratio	1.89
Short Shares	3.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-5.8M
Average Volume	62,595.8x
Bv Per Share	13.05
CAPEX	$-7,000
Ch1m	47.47
Ch1w	2.13
Ch1y	-98.33
Ch3m	27.21
Ch6m	213.7
Change	15.56%
Change From Open	16.38
Close	14.14
Days Gap	-0.71
Depreciation Amortization	342,000
Dollar Volume	2,513,565.9
Earnings Date	2026-06-17
EBIT	$-6.2M
EBITDA	$-5.9M
EPS	$-4.9
F Score	1
FCF	$-4.5M
FCF EV Yield	-24.76x
FCF Per Share	$-2.42
Financing CF	19,814,000
Fiscal Year End	December
Founded	2,005
Investing CF	-16,534,000
Ipr	273.1
Iprfo	-99.34
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-11
Last Report Date	2025-12-31
Last Split Date	2025-11-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-25
Ma150	10.91
Ma150ch	49.78%
Ma20	14.05
Ma20ch	16.34%
Net CF	-1,248,000
Next Earnings Date	2026-06-17
Open	14.04
Optionable	No
Position In Range	75.07
Post Close	16.34
Postmarket Change Percent	-2.08
Postmarket Price	$16
Ppne	12,000
Pre Close	14.14
Price Date	2026-05-08
Ptbv Ratio	1.66
Relative Volume	2.46x
Share Based Comp	1,310,000
Tr6m	213.71%
Volume	153,829

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PLRZ pay a dividend?

Capital-return profile for this ticker.

Performance

PLRZ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PLRZ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.2%

Float: +88.1% of shares outstanding

Insider ownership

+4.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PLRZ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.5

Neutral momentum band

Price vs 200-day MA

+65.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PLRZ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PLRZ stock rating?

Polyrizon Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PLRZ analysis?

The full report lives at /stocks/PLRZ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PLRZ?

The latest report frames PLRZ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PLRZ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.